Walleye Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Walleye Capital's GSK Position: Q3 2026 in Review
Walleye Capital reduced its GSK (GSK) stake by 48% in Q3 2026, selling an estimated $9.9M and leaving 208,289 shares worth $10M. The position accounts for 0.01% of the portfolio, ranked #1266.
Walleye Capital first reported a position in GSK in Q3 2018 and has held it in 13 quarters since. The position peaked at $21.1M in Q2 2026. 992 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Walleye Capital held 208,289 shares of GSK worth $10M as of Q3 2026.
- Walleye Capital sold 194,183 GSK shares in Q3 2026, an estimated $9.9M.
- GSK made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #1266 holding.
- Walleye Capital first reported a position in GSK in Q3 2018 and has held it in 13 quarters since.
- Walleye Capital's GSK position peaked at $21.1M in Q2 2026.
- 992 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.